TrialPath
Recruiting

Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study

NCT07931170 · Pediatric Nephrology Research Consortium
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
This study is designed to look at the natural history of glomerular diseases in children and adolescents in order to direct the research to find cures. This study will also possibly help identify or locate participants that may be eligible for clinical trials. Mixed retrospective-prospective cohort study (longitudinal, observational, non-interventional study) to research the natural history of glomerular disease in children and adolescents in the US. Objective: Evaluate the natural history of glomerular disease in children in the United States. Aim 1: To investigate and determine important relationships among patient/disease characteristics, natural history, treatments, histopathology, and outcomes among pediatric patients with glomerular disease, both across and within pre-specified disease cohorts (see below), by means of multicenter collection, storage, and analysis of longitudinal data. Aim 2: To provide a platform for and facilitate, with participant consent, rapid assessment of potential participant eligibility for planned and/or ongoing investigator-initiated and/or industry-sponsored clinical trials of pediatric glomerular disease. 20 initial sites were selected to recruit participants with glomerular disease. Patients diagnosed starting in July 2023, as well as newly diagnosed patients can be enrolled. Participants will be followed until 21 years of age. Data Collection at 6 month timepoints +/- 30 days. Collection starts with demographic information, medical history, and family medical history. Also collected at enrollment and at each time point are standard of care labs, hospitalizations, renal biopsy images, pathology reports and specialized or genetic testing. Participants will be asked to answer quality of life and social determinate of health questionnaires at enrollment and annually. These are optional and will not affect eligibility. Enrollment expected to be 500 participants per year.
Eligibility criteria
Inclusion Criteria: Children with biopsy-proven glomerular disease or populations with a clinical diagnosis of glomerular disease Exclusion Criteria: Patients who declined (or unable to provide informed consent, + informed assent of minors) to participate Patients with End Stage Kidney Disease (Stage 5 CKD, eGFR \< 15mL/min/1.73m2)
Study design
Enrollment target: 1000 participants
Age groups: child, adult
Timeline
Starts: 2026-10-01
Estimated completion: 2032-06
Last updated: 2026-11-12
Primary outcomes
  • • Proteinuria, and change over time thereof (urine protein-creatinine ratio) (Baseline and follow up timepoints (every 6 months) post-diagnosis to be reviewed at end of years 1 and 2 of data collection)
Sponsor
Pediatric Nephrology Research Consortium · other
With: Johns Hopkins All Children's Hospital, Washington University School of Medicine, Novartis
Contacts & investigators
ContactAmy Dutcher, MCR · contact · adutcher@PNRConsortium.org · 6145547621
ContactTeri Crumb, MSN, RN, CCRC · contact · teri@pnrconsortium.org · 616-607-4430
InvestigatorCarla Nester, MD · principal_investigator, University of Iowa
InvestigatorWilliam Smoyer, MD · principal_investigator, Nationwide Children's Hospital
InvestigatorJoseph Gaut, MD, PhD · principal_investigator, Washington University School of Medicine
All locations (2)
Boston Children's HospitalRecruiting
Boston, Massachusetts, United States
Cincinnati Children's Hospital Medical CenterRecruiting
Cincinnati, Ohio, United States